Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lan Mi

Showing results (191-200 of 221) with videos related to

Pageof 23
Sort By:
Bioresource Technology|October 12, 2010
Purification and characterization of a novel NADH-dependent carbonyl reductase from Pichia stipitis involved in biosynthesis of optically pure ethyl (S)-4-chloro-3-hydroxybutanoateHou Cao, Lan Mi, Qi Ye, et al.
Cancer Cell International|July 21, 2017
EP300 single nucleotide polymorphism rs20551 correlates with prolonged overall survival in diffuse large B cell lymphoma patients treated with R-CHOPJiao Li, Ning Ding, Xiaogan Wang, et al.
Applied Microbiology and Biotechnology|August 21, 2010
Biocatalytic synthesis of (S)-4-chloro-3-hydroxybutanoate ethyl ester using a recombinant whole-cell catalystQi Ye, Hou Cao, Guanglou Zang, et al.
The British Journal of Ophthalmology|August 14, 2025
Association between early lesion response and long-term anti-VEGF injection frequency in nAMD: a 2-year prospective study using 3D volumetric analysisJiaxin Pu, Xuenan Zhuang, Miaoling Li, et al.
China CDC Weekly|February 21, 2022
The Incidence of Lymphoma in Beijing: Comparing Results from MIS-CASS (2019) and Beijing Cancer Registry (2017)Hongrui Tian, Weiping Liu, Yuqin Song, et al.
Cancer Letters|May 30, 2024
PI3K inhibitor idelalisib enhances the anti-tumor effects of CDK4/6 inhibitor palbociclib via PLK1 in B-cell lymphomaDingyao Hu, Jiaowu Cao, Hui Yu, et al.
Hematological Oncology|April 27, 2022
Anti-CD47 immunotherapy in combination with BCL-2 inhibitor to enhance anti-tumor activity in B-cell lymphomaMiaomiao Li, Hui Yu, Fei Qi, et al.
Computational and Structural Biotechnology Journal|August 11, 2022
A comprehensive multi-omics analysis reveals molecular features associated with cancer via RNA cross-talks in the Notch signaling pathwayLi Guo, Sunjing Li, Xiaoqiang Yan, et al.
Toxicology in Vitro : an International Journal Published in Association with BIBRA|April 20, 2016
PINK1/Parkin-mediated mitophagy play a protective role in manganese induced apoptosis in SH-SY5Y cellsHong-Tao Zhang, Lan Mi, Ting Wang, et al.
BMC Cancer|November 12, 2017
TP53 Arg72 as a favorable prognostic factor for Chinese diffuse large B-cell lymphoma patients treated with CHOPYalu Liu, Xiaogan Wang, Ning Ding, et al.
Pageof 23

Showing results (191-200 of 221) with videos related to

Sort By:
Pageof 23
Bioresource Technology|October 12, 2010
Purification and characterization of a novel NADH-dependent carbonyl reductase from Pichia stipitis involved in biosynthesis of optically pure ethyl (S)-4-chloro-3-hydroxybutanoateHou Cao, Lan Mi, Qi Ye, et al.
Cancer Cell International|July 21, 2017
EP300 single nucleotide polymorphism rs20551 correlates with prolonged overall survival in diffuse large B cell lymphoma patients treated with R-CHOPJiao Li, Ning Ding, Xiaogan Wang, et al.
Applied Microbiology and Biotechnology|August 21, 2010
Biocatalytic synthesis of (S)-4-chloro-3-hydroxybutanoate ethyl ester using a recombinant whole-cell catalystQi Ye, Hou Cao, Guanglou Zang, et al.
The British Journal of Ophthalmology|August 14, 2025
Association between early lesion response and long-term anti-VEGF injection frequency in nAMD: a 2-year prospective study using 3D volumetric analysisJiaxin Pu, Xuenan Zhuang, Miaoling Li, et al.
China CDC Weekly|February 21, 2022
The Incidence of Lymphoma in Beijing: Comparing Results from MIS-CASS (2019) and Beijing Cancer Registry (2017)Hongrui Tian, Weiping Liu, Yuqin Song, et al.
Cancer Letters|May 30, 2024
PI3K inhibitor idelalisib enhances the anti-tumor effects of CDK4/6 inhibitor palbociclib via PLK1 in B-cell lymphomaDingyao Hu, Jiaowu Cao, Hui Yu, et al.
Hematological Oncology|April 27, 2022
Anti-CD47 immunotherapy in combination with BCL-2 inhibitor to enhance anti-tumor activity in B-cell lymphomaMiaomiao Li, Hui Yu, Fei Qi, et al.
Computational and Structural Biotechnology Journal|August 11, 2022
A comprehensive multi-omics analysis reveals molecular features associated with cancer via RNA cross-talks in the Notch signaling pathwayLi Guo, Sunjing Li, Xiaoqiang Yan, et al.
Toxicology in Vitro : an International Journal Published in Association with BIBRA|April 20, 2016
PINK1/Parkin-mediated mitophagy play a protective role in manganese induced apoptosis in SH-SY5Y cellsHong-Tao Zhang, Lan Mi, Ting Wang, et al.
BMC Cancer|November 12, 2017
TP53 Arg72 as a favorable prognostic factor for Chinese diffuse large B-cell lymphoma patients treated with CHOPYalu Liu, Xiaogan Wang, Ning Ding, et al.
Pageof 23